Conferences

Number of patients eligible for genome-driven oncology therapy is increasing, but the percentage who reportedly benefit from the therapy remains at less than 5% Advances in precision medicine in oncology (precision oncology) are fueling...

REGISTER NOW How do you decipher information from complex imaging technologies? Hyperplexing technologies have drastically increased the number of biomarkers that can be analyzed in tissue sections, but finding meaningful differences...

AIRA Matrix wins second place in the global Gleason 2019 Challenge at #MICCAI2019. The challenge involved automating the Gleason score, a highly reliable grading method for classifying the histologic characteristics of Prostate cancer. Our...

OR

platinum partners

gold partners

Silver Partners

Media Partners